Financials data is unavailable for this security.
View more
Year on year Parenteral Drugs (India) Ltd had revenues fall -30.17% from 121.68m to 84.96m, though the company grew net income from a loss of 1.22bn to a smaller loss of 763.62m.
| Gross margin | 35.67% |
|---|---|
| Net profit margin | -898.77% |
| Operating margin | -649.25% |
| Return on assets | -14.52% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2022, cash reserves at Parenteral Drugs (India) Ltd fell by 569.00k. However, Cash Flow from Investing totalled 647.25m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.83m for operations while cash used for financing totalled 642.99m.
| Cash flow per share | -12.15 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -276.37 |
|---|---|
| Tangible book value per share | -276.37 |
More ▼
Balance sheet in INRView more
| Current ratio | 0.0559 |
|---|---|
| Quick ratio | 0.055 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
